Comment
Author: Admin | 2025-04-28
Released.Patent expiration dates: April 23, 2024✓ Patent use: TREATMENT OF DISEASES OR CONDITIONS BY THE USE OF A DELAYED RELEASE 1, 2, OR 5 MG PREDNISONE TABLET April 23, 2024 Delayed release tablet with defined core geometryPatent 8,394,407Issued: March 12, 2013Inventor(s): Vergnault Guy & Grenier Pascal & Dragan ChristopheAssignee(s): Jagotec AGA tablet comprising a core containing an active agent, and a coating, the core being disposed within the coating such that the coating has a thickness about a longitudinal axis (X-Y) of about 4.85 to 4.95 mm. The position of the core within the coating dictating that the active agent is released rapidly after a lag time during which time no active agent is released.Patent expiration dates: April 23, 2024✓ Patent use: TREATMENT OF DISEASES OR CONDITIONS BY THE USE OF A DELAYED-RELEASE 1,2, OR 5MG PREDNISONE TABLET✓ Drug product Delayed release tablet with defined core geometryPatent 9,040,085Issued: May 26, 2015Inventor(s): Vergnault Guy & Grenier Pascal & Dragan ChristopheAssignee(s): Jagotec AGA tablet comprising a core containing an active agent, and a coating, the core being disposed within the coating such that the coating has a thickness about a longitudinal axis (X-Y) of about 4.85 to 4.95 mm. The position of the core within the coating dictating that the active agent is released rapidly after a lag time during which time no active agent is released.Patent expiration dates: April 23, 2024✓ Patent use: TREATMENT OF DISEASES OR CONDITIONS BY THE USE OF A DELAYED-RELEASE 1,2, OR 5MG PREDNISONE TABLET Delayed release tablet with defined core geometryPatent 9,186,332Issued: November 17, 2015Inventor(s): Vergnault Guy & Grenier Pascal & Dragan ChristopheAssignee(s): Jagotec AGA tablet comprising a core containing an active agent, and a coating, the core being disposed within the coating such that the coating has a thickness about a longitudinal axis (X-Y) of about 4.85 to 4.95 mm. The position of the core within the coating dictating that the active agent is released rapidly after a lag time during which time no active agent is released.Patent expiration dates: April 23, 2024✓ Patent use: TREATMENT OF DISEASES OR CONDITIONS BY THE USE OF A
Add Comment